Search for company
Explore more than 1.3 million company profiles from emerging markets

SMS Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 670.00
Volume 16,354
Turnover 10,897,897
Market Bombay Stock Exchange
Ticker 532815
Market Cap Market Cap 5,671,686
52 Week High 790.00
52 Week Low 388.15
P/E 16.09
EPS 41.63
Dividend Yield 1 (August 30, 2010)
Bookvalue 3,890,854
Enterprise Value 6,055,656
Quote updated on October 01, 2015
Note: data in INR Thousands.
Select Items to chart them. 2016 Q1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.
Company Description

SMS Pharmaceuticals Ltd. is a global player in API manufacturing industry. The company's products include Anti-Ulcer, Anti-fungal, Anti-migraine, Anti- Hypertensive,etc. Incorporated in 1987, SMS Pharma is based in Hyderabad.

Main Products

Intermediates & Other Products, Bulk Drugs,

Contact Information

Legal Address
Plot No. 19-III,, Opp. Bharatiya Vidya Bhavan Public School, Road No. 71, Jubilee Hills
Hyderabad; Andhra Pradesh; Map
Postal Code: 500096
Tel: 66288888
Fax: 23551401

Full name: SMS Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24239AP1987PLC008066
ISIN Code: INE812G01017
Incorporation Date: 1987

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2013: Imports INR 409,445,262,000.00 Thousands
Import connections ('000)
2013: Exports INR 1,102,219,221,000.00 Thousands
Export connections ('000)
Key Executives
Vice President - Operations
Ownership Details
Indian Promoters
Affiliates and related companies
SMS International Ltd.
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.